Yohannes Ghebremariam, Ph.D.
| Stanford University | # of Grants: 1 |
Grants
| Activation of DDAH for the Treatment of Atherosclerosis | 2011 (Cycle 20) | $87,350 |
| Cardiovascular Disease | Postdoctoral Fellowship Awards | |
Publications
| Development of a Dimethylarginine Dimethylaminohydrolase (DDAH) Assay for High-Throughput Chemical Screening | ||||
| Periodical: Journal of Biomolecular Screening | Index Medicus: | |||
| Authors: Ghebremariam YT, Erlanson DA, Yamada K and Cooke JP | ART | |||
| Yr: 2012 | Vol: 17 | Nbr: 5 | Abs: | Pg: 651-61 |
| Development of a Dimethylarginine Dimethylaminohydrolase (DDAH) Assay for High-Throughput Chemical Screening | ||||
| Periodical: Journal of Biomolecular Screening | Index Medicus: | |||
| Authors: Ghebremariam YT, Erlanson DA, Yamada K and Cooke JP | ART | |||
| Yr: 2012 | Vol: 17 | Nbr: 5 | Abs: | Pg: 651-61 |